Leader Biomedical Group expands its global footprint by establishing a new venture in Russia.
Online PR News – 27-July-2016 – AMSTERDAM, the NETHERLANDS 26 JULY 2016 – Leader Biomedical Group is further expanding its footprint into Russia with the establishment of Leader Biomedical RUS, LLC, in Moscow. This is yet another important milestone supporting the company’s mission to improve access to next generation technologies, products, and healthcare services across global markets.
Managing Director of Leader Biomedical RUS, Andrey Petropavlovskiy, will head up the Russian operations. He brings a strong experience in the sterilisation business and an existing network to Leader Biomedical that will support the company’s strategic direction, and drive activities towards making eCOO® Technology (our proprietary technology platform for the processing of various human and animal derived grafts) available to the Russian market.
Initial activities will concentrate on launching the Orthopaedic solutions for Total Hip/Knee Arthroplasty, as well as our range of PMMA bone cements, spine cements, and void fillers, which will address the current gap, and need in the Russian market. In addition, activities will include the introduction of Leader Biomedical’s proprietary eCOO® Technology platform, allowing for increased local access to robust technologies, and proven therapeutic solutions at an affordable cost of care.
“With support from the Leader Biomedical team, we were able to commence operations in under six months, and have already received our first orders for our line of knee reconstruction implants. We see increasing interest for our bone cements, and aim to launch the first biomaterials in the first half of 2017”, highlights Andrey Petropavlovskiy.
“There are strategic opportunities in catering to local healthcare establishments, and in providing affordable healthcare, with our line of therapeutic solutions, and manufacturing technologies. We are happy to partner with Andrey Petropavlovskiy, whose experience in this industry, and the Russian market will prove valuable in bringing our offerings to Russia.” adds Basil Babychan, Business Director, Leader Biomedical Group.
The incorporation of Leader Biomedical Russia follows those of Leader Biomedical Brazil, and Leader Biomedical India.